Acta Biomaterialia : Impact Factor & More
eISSN: 1878-7568pISSN: 1742-7061
Share this on:
Aims and Scope of Acta Biomaterialia
Acta Biomaterialia is a monthly peer-reviewed scientific journal published by Elsevier. It is published on behalf of Acta Materialia, Inc., and is sponsored by ASM International and The Minerals, Metals & Materials Society. The journal was established in January 2005. The editor-in-chief is W.R. Wagner (University of Pittsburgh). The journal covers research in biomaterials science, including the interrelationship of biomaterial structure and function from macroscale to nanoscale. Topical coverage includes biomedical and biocompatible materials. Less
Key Metrics
CiteScore 
15.6
Eigenfactor
0.01 - 0.05
Impact Factor
5 - 10
Scite Index
0.94 5-Year SI
SJR
Q1Biochemistry
SNIP
1.83
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Acta Biomaterialia
Acta Biomaterialia Journal Specifications
| Overview | |
| Publisher | ELSEVIER SCI LTD |
| Language | English |
| Frequency | Semi-monthly |
| General Details |
View less
Planning to publish in Acta Biomaterialia ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Acta Biomaterialia
Proteolysis-programmed reopening of bilayer hydrogel actuators.
- 1 Oct 2026
- Acta biomaterialia
Multiscale heterostructured Mg-2Zn alloy for biodegradable implants: Coordinated strength-ductility, moderate degradation, and immunomodulation.
- 1 Oct 2026
- Acta biomaterialia
Harnessing the dual role of reactive oxygen species in bacterial infection: Therapeutic opportunities for controlled release and targeted modulation.
- 1 Oct 2026
- Acta biomaterialia
Biomanufacturing Vascular Matrix-Mimetic Hydrogels from Quantified Arterial Micromechanics and Microstructure.
- 1 Oct 2026
- Acta biomaterialia
ROS- and iron ion-responsive gelatin modulates the pathological microenvironment to enhance myocardial infarction treatment.
- 1 Oct 2026
- Acta biomaterialia
Polymeric Nanoparticle Gene Delivery to Reprogram the Tumor Immune Microenvironment in Ovarian Cancer for an Anti-Tumor Response.
- 1 Oct 2026
- Acta biomaterialia
Proteolysis-programmed reopening of bilayer hydrogel actuators.
- 1 Oct 2026
- Acta biomaterialia
Multiscale heterostructured Mg-2Zn alloy for biodegradable implants: Coordinated strength-ductility, moderate degradation, and immunomodulation.
- 1 Oct 2026
- Acta biomaterialia
Harnessing the dual role of reactive oxygen species in bacterial infection: Therapeutic opportunities for controlled release and targeted modulation.
- 1 Oct 2026
- Acta biomaterialia
Biomanufacturing Vascular Matrix-Mimetic Hydrogels from Quantified Arterial Micromechanics and Microstructure.
- 1 Oct 2026
- Acta biomaterialia
ROS- and iron ion-responsive gelatin modulates the pathological microenvironment to enhance myocardial infarction treatment.
- 1 Oct 2026
- Acta biomaterialia
Polymeric Nanoparticle Gene Delivery to Reprogram the Tumor Immune Microenvironment in Ovarian Cancer for an Anti-Tumor Response.
- 1 Oct 2026
- Acta biomaterialia
FAQs on Acta Biomaterialia
How long has Acta Biomaterialia been actively publishing? 
What is the publishing frequency of Acta Biomaterialia?
How many articles did Acta Biomaterialia publish last year?
What is the eISSN & pISSN for Acta Biomaterialia?
What is Citescore for Acta Biomaterialia?
What is SNIP score for Acta Biomaterialia?
What is the SJR for Acta Biomaterialia?
Who is the publisher of Acta Biomaterialia?
